Anticoccidiosis pharmaceutical composition and method of preparing the same

A composition and anti-coccidial technology, applied in the directions of drug combinations, anti-infective drugs, pharmaceutical formulations, etc., can solve the problems of weakening and disappearing after two days, obvious adverse pharmacological effects, and high consumption of organic solvents, and can improve the health of the body. Resistance, improved bioavailability, wide range of effects

Inactive Publication Date: 2008-02-27
华云芳
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the drug has short duration of drug efficacy, poor drug dispersibility, and low bioavailability; traditional preparations use a lot of organic solvents, which are irritating and have obvious adverse pharmacological effects. Moreover, as long as th

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The anticoccidial pharmaceutical composition, its constituents and weight percentages are respectively:

[0028] Diclazuril 10% Vitamin K3 0.3%

[0029] Shigella net 0.8% DMF 30%

[0030] Tween-80 3% Ethanol 2%

[0031] Purified water 53.9%.

[0032] The steps of the preparation method of the anticoccidial pharmaceutical composition are:

[0033] (1). Fully mix diclazuril, vitamin K3, and dysentery net according to the weight ratio to form a drug mixture;

[0034] (2). Add auxiliary materials in the drug mixture according to the weight ratio, that is, add DMF, Tween-80, and ethanol respectively according to the weight ratio and stir evenly;

[0035] (3). Purified water is added according to the proportion, and the pH value is adjusted to 8 to obtain the finished product of anticoccidial pharmaceutical composition.

Embodiment 2

[0037] The anticoccidial pharmaceutical composition, its constituents and weight percentages are respectively:

[0038] Diclazuril 5% Vitamin K3 0.5%

[0039] Dysentery Net 1.2% DMF 20%

[0040] Tween-80 5% Ethanol 5%

[0041] Purified water 63.3%.

[0042] The steps of the preparation method of the anticoccidial pharmaceutical composition are:

[0043] (1). Fully mix diclazuril, vitamin K3, and dysentery net according to the weight ratio to form a drug mixture;

[0044] (2). Add auxiliary materials in the drug mixture according to the weight ratio, that is, add DMF, Tween-80, and ethanol respectively according to the weight ratio and stir evenly;

[0045] (3). Purified water is added according to the proportion, and the pH value is adjusted to 7 to obtain the finished product of anticoccidial pharmaceutical composition.

Embodiment 3

[0047] The anticoccidial pharmaceutical composition, its constituents and weight percentages are respectively:

[0048] Diclazuril 15% Vitamin K3 0.1%

[0049] Shigella net 0.4% DMF 40%

[0050] Tween-80 2% Ethanol 4%

[0051] Purified water 38.5%.

[0052] The steps of the preparation method of the anticoccidial pharmaceutical composition are:

[0053] (1). Fully mix diclazuril, vitamin K3, and dysentery net according to the weight ratio to form a drug mixture;

[0054] (2). Add auxiliary materials in the drug mixture according to the weight ratio, that is, add DMF, Tween-80, and ethanol respectively according to the weight ratio and stir evenly;

[0055] (3). Purified water is added according to the proportion, and the pH value is adjusted to 9 to obtain the finished product of anticoccidial pharmaceutical composition.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a coccidiostat composition and making method in medicinal composition field, which comprises the following parts: 5-15% diclazuril, 0. 1-1% vitamin K3, 0. 5-2% mequindox and 35-45% findings to add purified water to 100%. The invention is characterized by the following: adopting modern micro emulsion technology to produce; improving bioavailability of diclazuril to a great extent; extending releasing drug time with good dispersity and stable thermodynamic property and facilitating to absorb because of low viscosity; solving faults of strong irritation and conspicuously bad medicinal crop of overusing organic solvent drug of traditional agent; improving body's resisting power to achieve expecting treating effect. The invention can be used for diseases raised through all kinds of coccidian because of low toxicity and high efficient, which can be water-based drinking and used conveniently.

Description

technical field [0001] The invention belongs to the field of pharmaceutical compositions, in particular to an anticoccidial pharmaceutical composition and a preparation method thereof. Background technique [0002] Coccidia is one of the most common parasites in the aquaculture industry. It often parasitizes the epithelium of the intestinal mucosa, causing slow growth, loss of appetite, dysplasia, diarrhea or bloody dysentery, and can lead to dehydration and weight loss. Death, livestock, poultry, pets, special animals, etc. can be infected, easy to re-infect and difficult to remove. At the same time, parasitic coccidia can also damage the intestinal mucosal tissue and be easily attacked by pathogenic bacteria in the intestinal tract, resulting in secondary bacterial enteritis, resulting in accelerated death of sick animals, increasing the mortality of sick animals, and bringing great harm to the breeding industry. Huge economic loss. [0003] Diclazuril is currently one o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/53A61K47/34A61P33/02A61K31/498A61K31/122A61K47/26
Inventor 张兴龙华云芳
Owner 华云芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap